BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 28623863)

  • 1. Linear immunoglobulin A/G bullous dermatosis associated with ulcerative colitis.
    Onoe A; Matsuura D; Terui T; Ishii N; Hashimoto T; Ochiai T
    J Dermatol; 2017 Nov; 44(11):1295-1298. PubMed ID: 28623863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis.
    Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Sawamura D
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):116-117. PubMed ID: 34477081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review.
    Zhou Y; Zhou X; Feng X; Xia D; Qian H; Liu H; Li X; Li W
    Front Immunol; 2023; 14():1201163. PubMed ID: 37325615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three cases of linear IgA/IgG bullous dermatosis showing IgA and IgG reactivity with multiple antigens, particularly laminin-332.
    Sakaguchi M; Bito T; Oda Y; Kikusawa A; Nishigori C; Munetsugu T; Yokozeki H; Itotani Y; Niguma T; Tsuruta D; Tateishi C; Ishii N; Koga H; Hashimoto T
    JAMA Dermatol; 2013 Nov; 149(11):1308-13. PubMed ID: 24005769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear IgA bullous dermatosis associated with ulcerative colitis: A case report and literature review.
    Kanda N; Nakadaira N; Otsuka Y; Ishii N; Hoashi T; Saeki H
    Australas J Dermatol; 2020 Feb; 61(1):e82-e86. PubMed ID: 31319433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.
    Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ
    Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized linear IgA/IgG bullous dermatosis.
    Shimizu S; Natsuga K; Shinkuma S; Yasui C; Tsuchiya K; Shimizu H
    Acta Derm Venereol; 2010 Nov; 90(6):621-4. PubMed ID: 21057747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case of shift from linear immunoglobulin A bullous dermatosis to pemphigus herpetiformis for a short period of time.
    Koga H; Ishii N; Hashimoto T; Nakama T
    J Dermatol; 2017 Feb; 44(2):189-193. PubMed ID: 28497856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerative colitis complicated with linear immunoglobulin A bullous dermatosis.
    Ozaki R; Saito D; Mizukawa Y; Hisamatsu T
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35580954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA autoantibody may be the foremost pathogenic in three cases of linear IgA/IgG bullous dermatosis.
    Jing K; Wang Y; Li S; Feng S
    Australas J Dermatol; 2023 Aug; 64(3):e224-e228. PubMed ID: 37403826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence.
    Ohata C; Ishii N; Koga H; Nakama T
    Br J Dermatol; 2017 Jul; 177(1):152-157. PubMed ID: 27943257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
    Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
    J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear IgA/IgG bullous dermatosis reacts with multiple laminins and integrins.
    Li X; Tsuchisaka A; Qian H; Teye K; Ishii N; Sogame R; Harada K; Nakagomi D; Shimada S; Tateishi C; Hirako Y; Hashimoto T
    Eur J Dermatol; 2015; 25(5):418-23. PubMed ID: 26069157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA antibodies in chronic bullous disease of childhood react with 97 kDa basement membrane zone protein.
    Zone JJ; Taylor TB; Kadunce DP; Chorzelski TP; Schachner LA; Huff JC; Meyer LJ; Petersen MJ
    J Invest Dermatol; 1996 Jun; 106(6):1277-80. PubMed ID: 8752670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subepidermal blistering dermatosis associated with coexistent IgG and IgA anti-dermal basement membrane zone antibodies; demonstration of IgG antibodies reactive against a 200-kDa dermal antigen.
    Watanabe M; Tsunoda T; Tagami H
    Eur J Dermatol; 2002; 12(6):603-6. PubMed ID: 12459541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis.
    Osawa M; Demitsu T; Toda S; Yokokura H; Umemoto N; Yamada T; Yoneda K; Kakurai M; Yoshida M; Hashimoto T
    Dermatology; 2005; 211(2):146-8. PubMed ID: 16088162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear IgA bullous dermatosis with circulating IgG autoantibodies to the 230 kD epidermal antigen.
    Honoki K; Muramatsu T; Tsubakimoto A; Shirai T
    J Dermatol; 1998 Aug; 25(8):503-9. PubMed ID: 9769594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.
    Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA
    Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["Decoratively figured blisters" on the whole integument in initially diagnosed ulcerative colitis].
    Konschake W; Daeschlein G; Jünger M; Lutze S
    Hautarzt; 2019 Mar; 70(3):210-214. PubMed ID: 30460586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.